Efficiency of Cruroplasty as a Treatment of Gastro-Esophageal Reflux Disease in Morbid Obese Patients with Hiatus Hernia During Sleeve-Gastrectomy

Abstract

besity is known to be an independent risk factor for the development of both GERD and HH which present in about 37%–50% of morbidly obese patients undergoing bariatric surgery while 50%–70% of the patients undergoing this surgery have symptomatic reflux. Bariatric surgery is the only proven and effective long-term treatment for morbid obesity. The number of bariatric surgeries performed has increased significantly. Laparoscopic sleeve gastrectomy (SG) is becoming a very popular stand-alone weight loss procedure, and the number of primary SG cases being performed is increasing dramatically. SG has proven to be a very safe procedure with excellent short- and intermediate-term weight loss results. Laparoscopic anti-reflux surgery with HH repair (HHR) is generally the standard of care for the management of GERD. However, in morbidly obese patients with HH and/or GERD, bariatric surgery is the preferred treatment modality, Laparoscopic Roux-en-Y bypass (LNYGB) with or without crural closure is known to improve GERD and HH.